BioLight Life Sciences Ltd. (TLV:BOLT)
Israel · Delayed Price · Currency is ILS · Price in ILA 234.30
+16.40 (7.53%)
Apr 3, 2026, 1:44 PM IDT
BioLight Life Sciences Market Cap
BioLight Life Sciences has a market cap or net worth of 21.2 million as of April 2, 2026. Its market cap has decreased by -9.70% in one year.
Market Cap
21.20M
Enterprise Value
4.23M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
234.30
Market Cap Chart
Since January 11, 2006, BioLight Life Sciences's market cap has decreased from 47.74M to 21.20M, a decrease of -55.60%. That is a compound annual growth rate of -3.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 3, 2026 | 21.20M | -33.40% |
| Dec 31, 2025 | 31.83M | 25.69% |
| Dec 31, 2024 | 25.32M | 4.99% |
| Dec 31, 2023 | 24.12M | -19.99% |
| Dec 29, 2022 | 30.15M | -42.70% |
| Dec 30, 2021 | 52.62M | 53.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bonus BioGroup | 464.92M |
| Geffen Residence & Renewal | 271.49M |
| Matricelf | 99.34M |
| Clal Biotechnology Industries | 50.03M |
| BioLineRx | 31.33M |
| Evogene | 25.42M |
| Can-Fite BioPharma | 21.79M |
| XTL Biopharmaceuticals | 18.92M |